AUTOLOGOUS VERSUS HAPLOIDENTICAL DONOR STEM CELL TRANSPLANTATION FOR FAVORABLE-AND INTERMEDIATERISK ACUTE MYELOID LEUKEMIA IN FIRST REMISSION AND UNDETECTABLE MINIMAL RESIDUAL DISEASE: A MULTI-CENTER, PROSPECTIVE STUDY

被引：0
|
作者：
Ding, Yiyang [1 ]
Ru, Yuhua [1 ]
Zhu, Jinjin [1 ]
Zhang, Xi [2 ]
Liu, Lin [3 ]
Jiang, Erlie [4 ]
Huang, He [5 ]
Wang, Jishi [6 ]
Hu, Jiong [7 ]
Zhang, Yanming [8 ,9 ]
Xu, Yajing [10 ]
Yang, Mingzhen [11 ]
Chen, Jia [1 ]
Wu, Depei [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis, Suzhou, Peoples R China
[2] Third Mil Med Univ, Xinqiao Hosp, Chongqing, Peoples R China
[3] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R China
[5] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou, Peoples R China
[6] Guizhou Med Univ, Affiliated Hosp, Guiyang, Peoples R China
[7] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Natl Res Ctr Translat Med Shanghai, Ruijin Hosp,Sch Med,Shanghai Inst Hematol, Shanghai, Peoples R China
[8] Xuzhou Med Coll, Huaian Hosp, Huaian, Peoples R China
[9] Huaian Second Peoples Hosp, Huaian, Peoples R China
[10] Cent South Univ, XiangYa Hosp, Changsha, Peoples R China
[11] Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P001
引用
收藏
页码：140 / 141
页数：2
相关论文
共 50 条
  • [21] Minimal Residual Disease Predicts the Outcome of Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia in the First Remission
    Konova, Zoya
    Parovichnikova, Elena
    Galtseva, Irina
    Kapranov, Nikolay
    Davydova, Julia
    Drokov, Mikhail
    Vasilyeva, Vera
    Kuzmina, Larisa
    Kulikov, Sergey
    Julhakyan, Hunan
    Savchenko, Valeriy
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S296 - S296
  • [22] Haploidentical vs autologous hematopoietic stem cell transplantation in patients with acute leukemia beyond first remission
    S Singhal
    P J Henslee-Downey
    R Powles
    K Y Chiang
    K Godder
    J Treleaven
    S Kulkarni
    F van Rhee
    B Sirohi
    C R Pinkerton
    S Meller
    B Jovanovic
    J Mehta
    Bone Marrow Transplantation, 2003, 31 : 889 - 895
  • [23] Haploidentical vs autologous hematopoietic stem cell transplantation in patients with acute leukemia beyond first remission
    Singhal, S
    Henslee-Downey, PJ
    Powles, R
    Chiang, KY
    Godder, K
    Treleaven, J
    Kulkarni, S
    van Rhee, F
    Sirohi, B
    Pinkerton, CR
    Meller, S
    Jovanovic, B
    Mehta, J
    BONE MARROW TRANSPLANTATION, 2003, 31 (10) : 889 - 895
  • [24] Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison
    Cornelissen, Jan J.
    van der Holt, Bronno
    Verhoef, Gregor E. G.
    van 't Veer, Mars B.
    van Oers, Marinus H. J.
    Schouten, Harry C.
    Ossenkoppele, Gert
    Sonneveld, Pieter
    Maertens, Johan
    Kooy, Marinus van Marwijk
    Schaafsma, Martijn R.
    Wijermans, Pierre W.
    Biesma, Douwe H.
    Wittebol, Shulamit
    Voogt, Paul J.
    Baars, Joke W.
    Zachee, Pierre
    Verdonck, Leo F.
    Lowenberg, Bob
    Dekker, Adriaan W.
    BLOOD, 2009, 113 (06) : 1375 - 1382
  • [25] Comparison of Matched/Mismatched Unrelated Donor Stem Cell Transplantation to Autologous Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission: A Study from the Acute Leukemia Working Party of the EBMT
    Saraceni, F.
    Labopin, M.
    Gorin, N. -C.
    Blaise, D.
    Tabrizi, R.
    Volin, L.
    Cornelissen, J.
    Cahn, J. -Y.
    Chevallier, P.
    Craddock, C.
    Depei, W.
    Huynh, A.
    Arcese, W.
    Mohty, M.
    Nagler, A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S7 - S8
  • [26] Minimal residual disease (MRD) monitoring after autologous stem cell transplantation (auSCT) in acute myeloid leukemia (AML).
    Venditti, A
    Buccisano, F
    Del Poeta, G
    Tamburini, A
    Maurillo, L
    Postorino, M
    Picardi, A
    Riccitelli, A
    Amadori, S
    BLOOD, 2000, 96 (11) : 311A - 311A
  • [27] Autologous stem cell transplantation as post remission therapy for acute myeloid leukemia - a single center experience
    Candoni, A
    Sperotto, A
    Tomadini, V
    Fili, C
    Damiani, D
    Fanin, R
    BONE MARROW TRANSPLANTATION, 2003, 31 : S185 - S185
  • [28] Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMT
    Jia Chen
    Myriam Labopin
    Thomas Pabst
    Xi Zhang
    Erlie Jiang
    Alessandra Tucci
    Jan Cornelissen
    Ellen Meijer
    Irma Khevelidze
    Emmanuelle Polge
    Depei Wu
    Mohamad Mohty
    Norbert-Claude Gorin
    Bone Marrow Transplantation, 2023, 58 : 1322 - 1330
  • [29] Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMT
    Chen, Jia
    Labopin, Myriam
    Pabst, Thomas
    Zhang, Xi
    Jiang, Erlie
    Tucci, Alessandra
    Cornelissen, Jan
    Meijer, Ellen
    Khevelidze, Irma
    Polge, Emmanuelle
    Wu, Depei
    Mohty, Mohamad
    Gorin, Norbert-Claude
    BONE MARROW TRANSPLANTATION, 2023, 58 (12) : 1322 - 1330
  • [30] Autologous versus allogeneic stem cell transplantation in adults with acute myeloid leukemia (AML) in first remission (BGMT 91 protocol).
    Reiffers, J
    Stoppa, AM
    Huguet, F
    Molina, L
    Marit, G
    Blaise, D
    Attal, K
    Rossi, JF
    Sotto, JJ
    Faberes, C
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 206 - 206
12345